DINGYI GP INV (00508) announced its mid-year performance with a net loss of approximately HK$485 million, compared to a profit in the same period last year.

DINGYI GP INV (00508) announced its interim financial performance for the six months ending on September 30, 2025. The revenue was approximately HK$252 million, a year-on-year growth of 44.59%; the net loss was about HK$485 million, a year-on-year change from profit to loss; and the loss per share was 57.05 HK cents. The announcement stated that the change from profit to loss was mainly due to the following comprehensive impacts: (1) impairment loss provision for receivables and interest of approximately HK$20 million (compared to impairment loss of approximately HK$12 million in 2024); (2) increase in general and administrative expenses of approximately HK$16 million; (3) decrease in income from changes in fair value of financial assets of approximately HK$25 million; (4) disposal of development properties and completed properties held for sale amounting to HK$40.5 million; and (5) loss from repayment of financial liabilities of approximately HK$230 million.